AGMB
AgomAb Therapeutics NV American Depositary SharesNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
$8.81-3.08%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -28.3%
- 3 months
- -30.2%
- 1 year
- —
- Dividend
- No dividends on record
- Short interest
- 8.7% of float1M shares · settled Sep 30, 2026 · +15.4% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if AGMB is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: HIGH
18 top institutions tracked
as of 2026-Q2 (filed 2026-08-19)
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bullish
Last trade: buy 5 days ago
Red flags: 0
Largest 13-F holders · Q2 2026
34 filers reported a long position in AGMB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| EQT Fund Management S.a r.l. | $66.7M | 5.1M | Unchanged |
| Sanofi | $36.1M | 2.8M | Unchanged |
| Redmile Group, LLC | $35.5M | 2.7M | +1,649.7% |
| Cormorant Asset Management, LP | $32M | 2.5M | Unchanged |
| TCG Crossover Management, LLC | $26.7M | 2.1M | Unchanged |
| FEDERATED HERMES, INC. | $21M | 1.6M | Unchanged |
| Nantahala Capital Management, LLC | $20.4M | 1.6M | +30.7% |
| Casdin Capital, LLC | $20.1M | 1.6M | Unchanged |
| Andera Partners | $20M | 1.5M | Unchanged |
| FMR LLC | $18.9M | 1.5M | Unchanged |
Get the Full Analysis for AGMB
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.